Try GOLD - Free

LEADING WITH INNOVATION

Healthcare Radius

|

June 2024

"Every regional market presents a unique set of challenges and opportunities," said Ms Zahabiya Khorakiwala, Managing Director, Wockhardt Hospitals Group, during Healthcare Radius Leadership Vidcast.

- Ms Zahabiya Khorakiwala

LEADING WITH INNOVATION

She discussed at length the hospital's business and technology focus, people strategy, and her vision for the future. Excerpts from the vidcast:

Wockhardt Hospitals Group is completing 25 years this year. Looking back, what are the top three achievements of the hospital that you are proud of as a business leader?

Reflecting on our 25-year journey, I am proud of several key achievements. We were the pioneers in recognizing the need for high-quality healthcare in tier-2 and tier-3 cities. Initially, patients from these areas had to travel to metros for advanced medical treatments. By establishing hospitals in these regions, we have improved the standard of healthcare available locally.

We have successfully built a robust presence in metro, notably with the establishment of our state-of-the-art South Mumbai facility. Our hospital in Mumbai Central received JCI accreditation within its first three years, showcasing our adherence to international standards.

We have integrated advanced medical technologies and specialized services, such as our multidisciplinary regenerative medicine center, which has immense potential in various therapeutic areas. These efforts have cemented Wockhardt Hospitals as a leader in patient-centric care in India.

Tell us about your experience of setting up the Mumbai Central Hospital.

The Mumbai Central Hospital project was particularly significant as we built it from the ground up. Opening in 2014, this facility, along with our Mira Road hospital established a strong presence for us in Mumbai. The competitive market in South Mumbai was challenging, but we stayed true to our core philosophy of having full-time consultants, complemented by a network of visiting consultants.

MORE STORIES FROM Healthcare Radius

Healthcare Radius

Healthcare Radius

VENUS REMEDIES GETS DRUG APPROVALS IN VIETNAM

Venus Remedies, a fixed-dosage injectable manufacturer, has secured new marketing authorisations for Methotrexate, Cefuroxime, and Irinotecan in Vietnam.

time to read

1 mins

December 2025

Healthcare Radius

Healthcare Radius

A HEALTHIER INDIA IN THE MAKING: LEADERS DECODE THE ROAD FROM 2025 TO 2026

The collective goal is clear and unanimous: to transition from a system that primarily treats sickness to one that actively promotes lifelong health and well-being.

time to read

12 mins

December 2025

Healthcare Radius

Healthcare Radius

FROM GENES TO CARE: ADVANCING CLINICAL UNDERSTANDING OF HYPOPHOSPHATASIA

From genes to care, the story of hypophosphatasia reminds us that progress in medicine isn't only about scientific discovery, it's about turning knowledge into healing.

time to read

6 mins

December 2025

Healthcare Radius

ALEMBIC PHARMA GETS USFDA NOD FOR DILTIAZEM TABLETS IN THE US

Alembic Pharmaceuticals (Alembic) Aamour announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Diltiazem Hydrochloride Tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg.

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

ZYDUS GETS USFDA APPROVAL FOR PROSTATE CANCER INJECTABLE

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial (USRLD: Lupron Injection®, 1 mg/0.2 mL).

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

SUPERHEALTH LAUNCHES HONEST SECOND OPINION FOR PATIENTS

Superhealth, a zero-wait, commission Superhealth, zerohospital network, announced the launch of \"Honest Second Opinion,\" a service that helps patients make informed decisions about their treatment plans and surgical recommendations.

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

KOTAK ALTS INVESTS RS 400MN IN MEDIVERSAL

Kotak Alternate Asset Managers (Kotak Alts), through its Kotak Life Science Fund I, which invests in early to growth-stage life sciences and healthcare businesses, has made an investment of Rs 400 million in Mediversal Healthcare.

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

INVIGA HEALTHCARE FUND ACQUIRES 21% STAKE IN FORUS HEALTH

Inviga Healthcare Fund (IHF), the private equity platform founded by Dr B. S. Ajaikumar of HCG, has acquired a 21 per cent stake in Forus Health, an ophthalmic diagnostics company whose devices have screened over 22 million patients across 75+ countries.

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

OPTIMISING MATERNITY OPS: REDUCING C-SECTION BURDEN THROUGH EVIDENCE-BASED PROTOCOLS

By building systems that support safety, documentation, and respectful care, institutions can improve outcomes, lower litigation risks, and strengthen quality scores, achieving what healthcare should truly represent: Care Through Trust.”

time to read

7 mins

December 2025

Healthcare Radius

Healthcare Radius

MENTAL HEALTH CARE GOES DIGITAL WITH NEW THERAPY PLATFORM

Following the global observance and continuing the commitment to mental well-being, renowned clinical psychologist Kanika Jindal announced the launch of Harmony Therapy World, a holistic digital platform designed to bring emotional healing and psychological support to people everywhere, privately, compassionately, and without barriers.

time to read

1 min

December 2025

Listen

Translate

Share

-
+

Change font size